Management of Primary Pulmonary Artery Sarcomas

Shanda H. Blackmon, David C. Rice, Arlene M. Correa, Reza Mehran, Joe B. Putnam, W. Roy Smythe, Jon Cecil Walkes, Garrett L. Walsh, Cesar Moran, Harsh Singh, Ara A. Vaporciyan, Michael Reardon

Research output: Contribution to journalReview articlepeer-review

176 Scopus citations


The objective of this review is to determine the outcome of patients with sarcomas involving the main pulmonary artery, pulmonic valve, or right ventricular outflow tract. Survival data were analyzed using an aggregate series derived from the published literature in conjunction with a current series. Median survival was 36.5 ± 20.2 months for patients undergoing an attempt at curative resection compared with 11 ± 3 months for those undergoing incomplete resection. Median survival was 24.7 ± 8.5 months for patients undergoing multimodality treatment compared with 8.0 ± 1.7 months for patients having single-modality therapy. A complete review of diagnosis, evaluation, treatment, and surveillance of primary pulmonary artery sarcomas follows.

Original languageEnglish (US)
Pages (from-to)977-984
Number of pages8
JournalAnnals of Thoracic Surgery
Issue number3
StatePublished - Mar 2009

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Management of Primary Pulmonary Artery Sarcomas'. Together they form a unique fingerprint.

Cite this